ArticleChina CDC weekly2025
High Prevalence and Genomic Characterization of Extended-Spectrum
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Role of extended-spectrum β-lactamase (ESBL) genes in the dissemination of β-lactam resistance within aquatic environments: mechanisms, persistence, and one health implications.World journal of microbiology & biotechnology · 2026Review
- Virulome Landscape of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: The Yellow River serves as a significant conduit for antibiotic resistance transmission from environmental reservoirs to human populations. However, the occurrence and transmission pathways of the clinically relevant extended-spectrum β-lactamase (ESBL) gene What is added by this report?: This study reveals the widespread prevalence of What are the implications for public health practice?: The findings underscore the critical need to strengthen environmental surveillance and implement robust control measures targeting antibiotic resistance of animal origin. Additionally, we advocate for enhanced public awareness and education initiatives regarding antibiotic resistance to foster broader societal engagement and support for mitigation efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.